期刊文献+

5-FU纳米微粒的制备及其释药特性研究 被引量:6

Preparation of chitosan-5-fluorouracil nanometer particle and its drug-release characters
下载PDF
导出
摘要 目的制备一种新型的载氟尿嘧啶(5-FU)纳米微粒并对其体内释药特性进行研究。方法运用聚合物交联法制备出壳聚糖载氟尿嘧啶纳米粒,通过扫描电镜、激光粒度分析仪对其表征进行检测,紫外分光光度法测定载药量,高效液相色谱法检测体内的释药特性。结果壳聚糖载氟尿嘧啶纳米粒呈圆形或椭圆形,分散性良好,粒径在120-150nm;载药量为31.000%±0.001%;壳聚糖-5-FU纳米粒注射入兔体内后,初期突释相约在1.5h,峰浓度为5069.6μg/L,随即进入缓释相,浓度维持在76μg/L,时间长达48h。结论壳聚糖纳米药物载体可改变5-FU在体内的药代动力学行为,延长其循环时间,具有良好的缓释作用。 Objective To prepare the nanometer particles (NPs) of chitosan-5-fluorouracil (5-FU), and to study its characters of drug release in vivo. Methods Cross-linking polymer technique was employed to prepare the chitosan-5-FU NPs, and their characters were detected by scanning electron microscope and photon correlation spectroscope (PCS) ; the loaded capacity was measured by ultraviolet spectrophotometry; high-performance liquid chromatography was used to detect the characters of drug release in vivo. Results The chitosan-5-FU-NPs were found to be round or elliptic in shape, with 120 to 150nm in diameter and having a good dispersive ability. The loaded capacity was 31.000%±0. 001%. The blood concentration of 5-FU was controlled at 76μg/L, and it was maintained for 48h. Conclusion As a vehicle, chitosan-5-FU NPs can change the behavior of pharmacokinetics and prolong the cycle time of 5-FU in vivo. Chitosan-5-FU NPs ran reduce the initial burst and prolong the releasing time.
作者 孔璐 张阳德
出处 《解放军医学杂志》 CAS CSCD 北大核心 2007年第1期32-34,共3页 Medical Journal of Chinese People's Liberation Army
关键词 氟尿嘧啶 壳聚糖 海藻酸钠 药代动力学 fluorouracil chitosan sodium alginate pharmacokinetics
  • 相关文献

参考文献4

  • 1Mansouri S,Cuie Y,Winnik F,et al.Characterization of folate-chitosan-DNA nanoparticles for gene therapy.Biomaterials,2005,27(9):2060
  • 2Jacobs AH,Winkler A,Castro MG,et al.Human gene therapy and imaging in neurological diseases.Eur J Nucl Med Mol Imaging,2005,32(Suppl 2):S358
  • 3Winn SR,Hu Y,Sfeir C,et al.Gene therapy approaches for modulating bone regeneration.Adv Drug Deliv Rev,2000,42(1-2):121
  • 4李苏,姜文奇,王安训,管忠震,潘仕荣.5-FU核-壳型共聚物纳米胶束的制备及其体内释药的研究[J].癌症,2004,23(4):381-385. 被引量:17

二级参考文献10

  • 1By the meta-analysis Group in cancer. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer [J]. J Clin Oncol, 1998, 16:301- 308.
  • 2Kataoka K,Matsumoto T,Yokoyama M,et al. Doxorubicin-loaded poly (ethylene glycol)-poly (β-benzyl-L-aspartate) copolymer micelles: their pharmaceutical characteristics and biological significance [J]. J Control Rel,2000,64(1- 3):143.
  • 3Yasugi K,Nagasaki Y,Kato M,et al. Preparation and characterization of polymer micelles from poly(ethylene glycol)-poly(D,L-lactide) block copolymers as potential drug carrier [J]. J Controlled Release,1999, 62(1- 2):89.
  • 4赵锦花.新型药物载体—PEG修饰聚氰基丙烯酸纳米微球的制备及其性能研究 [J].天津大学学报,2001,58.
  • 5Sung BL,Teruo O,Kazunori K. Preparation and characterization of the micell-forming polymeric drug indomethacin-incorporated poly(ethelene oxide)-poly (β-benzyl L-aspartiate) block copolymer micelles [J]. J Pharm Sci,1996,85(1):85.
  • 6Couvreur P,Puisieux F. Nano and microparticles for the delivery of polypeptides and proteins [J]. Adv Drug Del Rev, 1993,10:141.
  • 7Sharma D,Chelvi TP,Kaur J,et al. Novel taxol(R) formulation:polyvinylpyrrolidone nanoparticle-encapsulate taxol(R) for drug delivery in cancer therapy [J]. Oncol Res,1996,8(7- 8):281- 286.
  • 8肖延龄,李伯.载药纳米微粒与中药现代化[J].中草药,2002,33(5):385-388. 被引量:7
  • 9冯敏,吴伟荣,潘仕荣.萘普生核-壳型共聚物纳米胶束的制备及特性[J].中国药学杂志,2002,37(7):509-512. 被引量:19
  • 10潘仕荣,冯敏.萘普生/聚乙二醇-聚谷氨酸苄酯共聚物纳米胶束[J].中山医科大学学报,2003,24(1):52-57. 被引量:7

共引文献16

同被引文献97

引证文献6

二级引证文献21

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部